LYVE1 and familial pancreatic carcinoma: For instance, in this study, SHAP analysis revealed LYVE1 and TFF1 as the most influential factors in predicting pancreatic cancer, therefore, clinicians can request extra confirmatory testing while validating these results against existing diagnostic parameters to prevent false diagnoses and unnecessary procedures.